People with multiple sclerosis (MS) often stop taking disease-modifying ... patients tend to experience fewer relapses and less disease activity but show more evidence of neuronal degeneration.

Mapping cell types in MS lesions reveals unique tissue niches and interactions, offering insights into the molecular drivers of multiple sclerosis progression.

Targeting ceramide synthase enzymes may reduce multiple sclerosis severity by limiting ceramide C16 synthesis, offering ...

Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Drugmakers had hoped that inhibiting receptor-interacting protein kinase would decrease inflammation and reduce neuronal degeneration in patients with multiple sclerosis and other neurodegenerative co ...

Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...

New research highlights how a palm oil-rich diet may worsen multiple sclerosis (MS) symptoms by generating a toxic compound ...

In PSP, there is gross midbrain atrophy and neuronal loss, gliosis and abundant neurofibrillary tangles and neuropil threads in many brain regions. There is a uniform presence of tau-positive ...

Many people may find it challenging to decide when to begin treatment for multiple sclerosis (MS). Faced with few symptoms and the prospect of side effects from medication, many people choose to ...

SIR Chris Hoy revealed his wife has been diagnosed with multiple sclerosis as the Scots Olympic ... for the low-risk course of action. MS is a degenerative and incurable disease.